A trial with fluocinonide in recalcitrant dermatoses

Area of Science:

• Dermatology
• Pharmacology

Background:

• Recalcitrant corticosteroid-responsive dermatoses pose treatment challenges.
• Previous topical corticosteroid treatments were often inadequate.

Purpose of the Study:

• To evaluate the efficacy and safety of fluocinonide 0.05% cream.
• To assess fluocinonide's effectiveness in patients with treatment-resistant dermatoses.

Main Methods:

• A single-blind trial involving 105 patients.
• Patients had previously failed treatment with other topical corticosteroids.
• Fluocinonide 0.05% cream was applied for three weeks.

Main Results:

• 71% of 93 analyzed patients achieved excellent to moderate improvement.
• Fluocinonide demonstrated effectiveness across 8 of 12 different diagnoses.
• Adverse effects were infrequent and minor.

Conclusions:

• Fluocinonide 0.05% cream is an effective and safe treatment option.
• It offers a viable solution for recalcitrant corticosteroid-responsive dermatoses.
• The study supports fluocinonide's utility in diverse dermatological conditions.